Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Oncology - Page 7

Oncology

The FDA approved new treatment option for patients with HER2-positive breast cancer
Biotechnology | FDA | Oncology | Therapeutics

The FDA approved new treatment option for patients with HER2-positive breast cancer

On Dec. 20, 2019, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Daiichi Sankyo’s Enhertu…

Read More The FDA approved new treatment option for patients with HER2-positive breast cancerContinue

The Cold Spring Harbor Laboratory researchers identified gene behind spread of deadly breast cancer
Biotechnology | Disease | Oncology | Therapeutics

The Cold Spring Harbor Laboratory researchers identified gene behind spread of deadly breast cancer

On Dec. 3, 2019, the Cold Spring Harbor Laboratory researchers with colleagues at UConn Health and Jackson Laboratory…

Read More The Cold Spring Harbor Laboratory researchers identified gene behind spread of deadly breast cancerContinue

The Cancer Prevention and Research Institute of Texas awarded 10 new recruitment grants
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Therapeutics

The Cancer Prevention and Research Institute of Texas awarded 10 new recruitment grants

On Nov. 20, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the recruitment of its…

Read More The Cancer Prevention and Research Institute of Texas awarded 10 new recruitment grantsContinue

Karmanos Cancer Institute established the McLaren Proton Therapy Center
Biotechnology | Diagnostics | Neurology | Non-Profit Research | Oncology | Radiology | Therapeutics

Karmanos Cancer Institute established the McLaren Proton Therapy Center

On Oct. 30, 2019, the Barbara Ann Karmanos Cancer Institute established the McLaren Proton Therapy Center, one of…

Read More Karmanos Cancer Institute established the McLaren Proton Therapy CenterContinue

Karmanos, Wayne State received $3.1 million NIH grant to improve quality of life for African American cancer survivors
Biotechnology | Diagnostics | Disease | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics

Karmanos, Wayne State received $3.1 million NIH grant to improve quality of life for African American cancer survivors

On Sept. 24, 2019 Karmanos, Wayne State announced it had received a $3.1 million National Institutes of Health…

Read More Karmanos, Wayne State received $3.1 million NIH grant to improve quality of life for African American cancer survivorsContinue

Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center received a $9.2 million grant from the National Cancer Institute
Biotechnology | Diagnostics | Oncology | Therapeutics

Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center received a $9.2 million grant from the National Cancer Institute

On Sept. 23, 2019, the Barbara Ann Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center…

Read More Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center received a $9.2 million grant from the National Cancer InstituteContinue

Pascal Biosciences discovered cannabinoids activate the major histocompatibility complex to aid cancer treatment
Biotechnology | Oncology | Therapeutics

Pascal Biosciences discovered cannabinoids activate the major histocompatibility complex to aid cancer treatment

On Sept. 23, 2019, Pascal Biosciences identified specific cannabinoids that enhance the immunogenicity of tumor cells, rendering them…

Read More Pascal Biosciences discovered cannabinoids activate the major histocompatibility complex to aid cancer treatmentContinue

Karmanos Cancer Institute became the first in Michigan to offer patients the Leksell Gamma Knife Icon stereotactic radiosurgery system
Biotechnology | Diagnostics | Neurology | Non-Profit Research | Oncology | Radiology | Therapeutics

Karmanos Cancer Institute became the first in Michigan to offer patients the Leksell Gamma Knife Icon stereotactic radiosurgery system

On Aug. 19, 2019, the Barbara Ann Karmanos Cancer Institute announced it became the first cancer center in…

Read More Karmanos Cancer Institute became the first in Michigan to offer patients the Leksell Gamma Knife Icon stereotactic radiosurgery systemContinue

CPRIT granted $18.7 million New Company Product Development award to Salarius Pharmaceuticals
Biotechnology | Disease | Non-Profit Research | Oncology | Pharmaceutical | Rare Disease | Therapeutics

CPRIT granted $18.7 million New Company Product Development award to Salarius Pharmaceuticals

On Aug. 15, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it was awarded…

Read More CPRIT granted $18.7 million New Company Product Development award to Salarius PharmaceuticalsContinue

Masonic Cancer Center researchers awarded $8.5 million dollar grant to research metastatic breast cancer
Biotechnology | Disease | Non-Profit Research | Oncology | Therapeutics

Masonic Cancer Center researchers awarded $8.5 million dollar grant to research metastatic breast cancer

On Aug. 15, 2019, Masonic Cancer Center researchers Reuben Harris, PhD and Douglas Yee, MD announced that they…

Read More Masonic Cancer Center researchers awarded $8.5 million dollar grant to research metastatic breast cancerContinue

Siteman Cancer Center awarded $7.8 million to expand clinical trials access
Biotechnology | Non-Profit Research | Oncology | Therapeutics

Siteman Cancer Center awarded $7.8 million to expand clinical trials access

On Aug. 1, 2019 the Siteman Cancer Center announced it was awarded a six-year, $7.8 million grant from…

Read More Siteman Cancer Center awarded $7.8 million to expand clinical trials accessContinue

Columbia Sportswear’s Tim and Mary Boyle announced a $10 million gift to OHSU Knight Cancer Institute
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Therapeutics

Columbia Sportswear’s Tim and Mary Boyle announced a $10 million gift to OHSU Knight Cancer Institute

On Jun. 18, 2019, Columbia Sportswear President and CEO Tim Boyle and his wife, Mary, announced a donation…

Read More Columbia Sportswear’s Tim and Mary Boyle announced a $10 million gift to OHSU Knight Cancer InstituteContinue

Winship Cancer Institute awarded prestigious Lung Cancer SPORE grant from NCI
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Vaccine

Winship Cancer Institute awarded prestigious Lung Cancer SPORE grant from NCI

On Jun. 10, 2019, the Winship Cancer Institute was awarded a five-year, $9.7 million Specialized Program of Research…

Read More Winship Cancer Institute awarded prestigious Lung Cancer SPORE grant from NCIContinue

The Cancer Prevention and Research Institute of Texas awarded a relocation grant to Hummingbird Bioscience
Biotechnology | Oncology | Therapeutics

The Cancer Prevention and Research Institute of Texas awarded a relocation grant to Hummingbird Bioscience

On Jun. 4, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded a $13 million relocation…

Read More The Cancer Prevention and Research Institute of Texas awarded a relocation grant to Hummingbird BioscienceContinue

Amgen announced the launch of Amgen Community Oncology Research Collaborators
Biotechnology | Diagnostics | Disease | Oncology | Therapeutics

Amgen announced the launch of Amgen Community Oncology Research Collaborators

On May 28, 2019, Amgen, along with leading community oncology networks, announced the launch of Amgen Community Oncology…

Read More Amgen announced the launch of Amgen Community Oncology Research CollaboratorsContinue

The FDA approved new formulation of Herceptin for subcutaneous use
Biotechnology | Disease | FDA | Oncology | Therapeutics

The FDA approved new formulation of Herceptin for subcutaneous use

On Feb. 28, 2019, the U.S. Food and Drug Administration (FDA) approved trastuzumab and hyaluronidase-oysk injection,for subcutaneous use…

Read More The FDA approved new formulation of Herceptin for subcutaneous useContinue

Perlmutter Cancer Center earned Comprehensive status from the National Cancer Institute
Biotechnology | Diagnostics | Disease | Medicine | Non-Profit Research | Oncology | Therapeutics

Perlmutter Cancer Center earned Comprehensive status from the National Cancer Institute

On Feb. 6, 2019, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health was designated a Comprehensive…

Read More Perlmutter Cancer Center earned Comprehensive status from the National Cancer InstituteContinue

Karmanos Cancer Institute awarded President’s Trophy by McLaren Health Care system
Biotechnology | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics

Karmanos Cancer Institute awarded President’s Trophy by McLaren Health Care system

On Jan. 24, 2019, the Barbara Ann Karmanos Institute received the President’s Trophy from McLaren Health Care system,…

Read More Karmanos Cancer Institute awarded President’s Trophy by McLaren Health Care systemContinue

Researchers discovered way to kill dormant, hiding breast cancer cells, an avenue for preventing relapse
Biotechnology | Diagnostics | Oncology | Radiology | Therapeutics

Researchers discovered way to kill dormant, hiding breast cancer cells, an avenue for preventing relapse

On Jan. 21, 2019, researchers at Fred Hutchinson Cancer Research Center announced finding a way to essentially smother…

Read More Researchers discovered way to kill dormant, hiding breast cancer cells, an avenue for preventing relapseContinue

Karmanos Cancer Institute and Wayne State University awarded prestigious LAPS grant
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Radiology | Therapeutics

Karmanos Cancer Institute and Wayne State University awarded prestigious LAPS grant

On Dec. 20, 2018, the Karmanos Cancer Institute and Wayne State University were awarded the prestigious LAPS Grant…

Read More Karmanos Cancer Institute and Wayne State University awarded prestigious LAPS grantContinue

Karmanos Morey Cancer Center recognized by the American Society of Clinical Oncology with the QOPI Certification Program
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Radiology | Therapeutics

Karmanos Morey Cancer Center recognized by the American Society of Clinical Oncology with the QOPI Certification Program

On Dec. 17, 2018, the Karmanos Morey Cancer Center was recognized by the American Society of Clinical Oncology…

Read More Karmanos Morey Cancer Center recognized by the American Society of Clinical Oncology with the QOPI Certification ProgramContinue

Pascal Biosciences announced optimization of cannabinoid-derived drug candidates to kill glioblastoma cells
Biotechnology | Medicine | Oncology

Pascal Biosciences announced optimization of cannabinoid-derived drug candidates to kill glioblastoma cells

On Nov. 15, 2018, Pascal Biosciences announced the peer reviewed publication of their licensed cannabinoid-derived drug program for…

Read More Pascal Biosciences announced optimization of cannabinoid-derived drug candidates to kill glioblastoma cellsContinue

Pascal Biosciences and the University of Washington announced exclusive license agreement to develop cannabinoid-based medicine for cancer
Biotechnology | Medicine | Neurology | Oncology | Therapeutics

Pascal Biosciences and the University of Washington announced exclusive license agreement to develop cannabinoid-based medicine for cancer

On Oct. 30, 2018, Pascal Biosciences announced the Company had entered into an exclusive license agreement with the…

Read More Pascal Biosciences and the University of Washington announced exclusive license agreement to develop cannabinoid-based medicine for cancerContinue

The National Cancer Institute awarded a $10.7 million grant to Abramson Cancer Center to study CAR T cells in solid tumors
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Radiology | Therapeutics

The National Cancer Institute awarded a $10.7 million grant to Abramson Cancer Center to study CAR T cells in solid tumors

On Oct. 22, 2018, the National Cancer Institute (NC) awarded a $10.7 million five year grant to Abramson…

Read More The National Cancer Institute awarded a $10.7 million grant to Abramson Cancer Center to study CAR T cells in solid tumorsContinue

Siteman Cancer Center to offer newest form of proton therapy
Biotechnology | Medical Device | Non-Profit Research | Oncology

Siteman Cancer Center to offer newest form of proton therapy

On Oct. 22, 2018, the Siteman Cancer Center announced a second proton therapy system that would incorporate pencil-beam…

Read More Siteman Cancer Center to offer newest form of proton therapyContinue

The Cancer Prevention and Research Institute announced the formation of the 2018 Texas Cancer Plan
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Therapeutics

The Cancer Prevention and Research Institute announced the formation of the 2018 Texas Cancer Plan

On Sept. 25, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the formation of the…

Read More The Cancer Prevention and Research Institute announced the formation of the 2018 Texas Cancer PlanContinue

The Cancer Prevention and Research Institute of Texas announced surpassed $2 billion in grants to fight cancer
Biotechnology | Diagnostics | Disease | Non-Profit Research | Oncology | Therapeutics | Women's Health

The Cancer Prevention and Research Institute of Texas announced surpassed $2 billion in grants to fight cancer

On Aug. 24, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it passed a $2…

Read More The Cancer Prevention and Research Institute of Texas announced surpassed $2 billion in grants to fight cancerContinue

UCSD researchers discovered that a type of DNA-repairing enzyme is neutralized by DNA lesions caused by exposure to ultraviolet light
Biotechnology | Non-Profit Research | Oncology | Therapeutics

UCSD researchers discovered that a type of DNA-repairing enzyme is neutralized by DNA lesions caused by exposure to ultraviolet light

On Aug. 22, 2018,  University of California, San Diego (UCSD) researchers with colleagues in Spain and Finland, described…

Read More UCSD researchers discovered that a type of DNA-repairing enzyme is neutralized by DNA lesions caused by exposure to ultraviolet lightContinue

Keck School of Medicine  announced $26.5 million grant to fund firstᅠ large-scale study on African-American men with prostate cancer
Biotechnology | Diagnostics | Medicine | NIH | Non-Profit Research | Oncology | Therapeutics

Keck School of Medicine announced $26.5 million grant to fund firstᅠ large-scale study on African-American men with prostate cancer

On Jul. 17, 2018, the Keck School of Medicine of USC announced that it was leading a $26.5…

Read More Keck School of Medicine announced $26.5 million grant to fund firstᅠ large-scale study on African-American men with prostate cancerContinue

Texas Life Science Genealogy, 2018
Agriculture | Biotechnology | Diagnostics | Disease | Life Science History | Medical Device | Oncology | Pharmaceutical | Veterinary

Texas Life Science Genealogy, 2018

Texas Life Science Genealogy illustrates life science companies and non-profit research organization in the State of Texas by…

Read More Texas Life Science Genealogy, 2018Continue

Page navigation

Previous PagePrevious 1 … 5 6 7 8 9 … 28 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiovascular
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search